Differential expression of miRNAs related to autophagy pathway in tissue and serum samples of colorectal cancer patients

被引:1
|
作者
Umit, Yilmaz [1 ,2 ]
Nesibe, Yilmaz [1 ,3 ]
Kevser, Tanbek [2 ,4 ]
Arzu, Ergen [1 ]
Nihat, Aksakal [5 ]
Umit, Zeybek [1 ]
机构
[1] Istanbul Univ, Aziz Sancar Inst Expt Med, Dept Mol Med, Istanbul, Turkey
[2] Inonu Univ, Fac Med, Dept Physiol, Malatya, Turkey
[3] Inonu Univ, Fac Med, Dept Anat, Malatya, Turkey
[4] Inonu Univ, Fac Med, Dept Biochem, Malatya, Turkey
[5] Istanbul Univ, Istanbul Fac Med, Dept Gen Surg, Istanbul, Turkey
来源
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY | 2022年 / 123卷 / 09期
关键词
colorectal cancer; autophagy; beclin-1; miRNA; biomarker; DOWN-REGULATION; TUMOR-SUPPRESSOR; EMERGING ROLES; INVASION; MIR-216B; METASTASIS; MIGRATION; CELLS; RADIOSENSITIVITY; OVEREXPRESSION;
D O I
10.4149/BLL_2022_102
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: This study was aimed to investigate the relationship of miR-17-5p, miR-30b, miR-30d, miR-216a and miR-216b associated with autophagy gene beclin 1, and beclin 1 gene with colorectal cancer (CRC).MATERIALS AND METHODS: Forty-seven patients with CRC and 50 healthy individuals with no cancer history were included in this study. In the serum, tumor and non-tumoral tissue samples of the CRC patients, and in the serum samples of the healthy subjects, expression levels of miRNAs were detected by qRT-PCR. The beclin 1 gene expression levels were determined by qRT-PCR, and protein levels were determined by Western blot method in tumor and non-tumor tissue samples of the patients.RESULTS: The miR-17-5p and miR-30d expressions were found to be higher in tumor tissue as compared to patient non-tumor tissues, while expressions of beclin-1, miR-30b and miR-216a were found to be lower. In addition, the beclin-1 protein levels were significantly decreased in the tumor tissue as compared to those in the patient non-tumor tissues. The miR-30d expression was significantly reduced in the serum of the patients when the serum samples of CRC patients and healthy controls were compared.CONCLUSION: The beclin 1 gene may play a role as a tumor suppressor in CRC. Moreover, these miRNAs cannot be used as highly reliable biomarkers in serum for CRC diagnosis (Tab. 2, Fig. 6, Ref. 46). Text in PDF www.elis.sk
引用
收藏
页码:634 / 640
页数:7
相关论文
共 50 条
  • [41] Effect of the Expression of Matrix Metalloproteases and Their Tissue Inhibitors on Survival of Patients with Resectable Colorectal Cancer
    Gonzalez, Lucia
    Eiro, Noemi
    Gonzalez, Luis O.
    Andicoechea, Alejandro
    Barbon, Esther
    Garcia-Muniz, Jose L.
    Vizoso, Francisco J.
    DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (08) : 2063 - 2071
  • [42] Molecular detection of exosomal miRNAs of blood serum for prognosis of colorectal cancer
    Bakhsh, Tahani
    Alhazmi, Safiah
    Farsi, Ali
    Yusuf, Abdulaziz S.
    Alharthi, Amani
    Qahl, Safa H.
    Alghamdi, Maha Ali
    Alzahrani, Faisal A.
    Elgaddar, Ola H.
    Ibrahim, Mohanad A.
    Bahieldin, Ahmed
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [43] Differential expression of alternatively spliced transcripts related to energy metabolism in colorectal cancer
    Snezhkina, Anastasiya Vladimirovna
    Krasnov, George Sergeevich
    Zaretsky, Andrew Rostislavovich
    Zhavoronkov, Alex
    Nyushko, Kirill Mikhailovich
    Moskalev, Alexey Alexandrovich
    Karpova, Irina Yurievna
    Afremova, Anastasiya Isaevna
    Lipatova, Anastasiya Valerievna
    Kochetkov, Dmitriy Vladimitovich
    Fedorova, Maria Sergeena
    Volchenko, Nadezhda Nikolaevna
    Sadritdinova, Asiya Fayazovna
    Melnikova, Nataliya Vladimirovna
    Sidorov, Dmitry Vladimirovich
    Popov, Anatoly Yurievich
    Kalinin, Dmitry Valerievich
    Kaprin, Andrey Dmitrievich
    Alekseev, Boris Yakovlevich
    Dmitriev, Alexey Alexandrovich
    Kudryavtseva, Anna Viktorovna
    BMC GENOMICS, 2016, 17
  • [44] The BAX gene as a candidate for negative autophagy-related genes regulator on mRNA levels in colorectal cancer
    Gil, Justyna
    Ramsey, David
    Szmida, Elzbieta
    Leszczynski, Przemyslaw
    Pawlowski, Pawel
    Bebenek, Marek
    Sasiadek, Maria M.
    MEDICAL ONCOLOGY, 2017, 34 (02)
  • [45] Natural Compounds Targeting the Autophagy Pathway in the Treatment of Colorectal Cancer
    Du, Yin-Xiao
    Mamun, Abdullah Al
    Lyu, Ai-Ping
    Zhang, Hong-Jie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [46] Expression and significance of cyclooxygenase-2 in colorectal cancer and the colorectal adenomas tissue
    Li, Xiaofeng
    Kong, Lixia
    Liao, Suhuan
    Lu, Jing
    Ma, Lin
    Long, Xiaohua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 3449 - 3456
  • [47] Evaluation of genetic variants in miRNAs in patients with colorectal cancer
    Dikaiakos, Panagiotis
    Gazouli, Maria
    Rizos, Spyros
    Zografos, George
    Theodoropoulos, George E.
    CANCER BIOMARKERS, 2015, 15 (02) : 157 - 162
  • [48] MTHFD1 Regulates Autophagy to Promote Growth and Metastasis in Colorectal Cancer via the PI3K-AKT-mTOR Signaling Pathway
    Li, Zhihao
    Ke, Haoxian
    Cai, Jiawei
    Ye, Shubiao
    Huang, Junfeng
    Zhang, Chi
    Yuan, Ming
    Lan, Ping
    Wu, Xianrui
    CANCER MEDICINE, 2024, 13 (22):
  • [49] Differential Expression and Prognostic Role of Selected Genes in Colorectal Cancer Patients
    Pitule, Pavel
    Vycital, Ondrej
    Bruha, Jan
    Novak, Petr
    Hosek, Petr
    Treska, Vladislav
    Hlavata, Ivona
    Soucek, Pavel
    Kralickova, Milena
    Liska, Vaclav
    ANTICANCER RESEARCH, 2013, 33 (11) : 4855 - 4865
  • [50] Serum level and tumor tissue expression of Ribonucleotide-diphosphate Reductase subunit M2 B: a potential biomarker for colorectal cancer
    Mobarra, Naser
    Gholamalizadeh, Hanieh
    Abdulhussein, Kaed A.
    Raji, Sara
    Asl, Fatemeh Taheri
    Mirvahabi, Mobina Sadat
    Rafiee, Mahdi
    Pakzad, Reza
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (05) : 3657 - 3663